Could lymphocyte to C‐reactive protein ratio predict the prognosis in patients with gastric cancer?
Yazarlar (4)
Dr. Öğr. Üyesi Yavuz Selim Angın İnönü Üniversitesi, Türkiye
Doç. Dr. Murat YILDIRIM Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Doç. Dr. Mehmet Fatih DAŞIRAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. İsmail Okan İstanbul Medeniyet Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı ANZ Journal of Surgery (Q3)
Dergi ISSN 1445-1433 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 12-2021
Cilt / Sayı / Sayfa 91 / 7 / 1521–1527 DOI 10.1111/ans.16913
Makale Linki http://dx.doi.org/10.1111/ans.16913
UAK Araştırma Alanları
Genel Cerrahi
Özet
Background Development or progression of inflammation in neoplastic diseases is known to be part of the disease. Lymphocyte to C‐reactive protein ratio (LCR) is a new indicator showing the inflammatory state. The aim of this study is to show the clinical importance of the relationship between the preoperative LCR and the prognosis of patients with gastric cancer. Methods and Patients We evaluated gastric cancer patients, who underwent surgery between 2010 and 2015. LCR and neutrophil‐to‐lymphocyte ratio (NLR) were calculated from pre‐treatment of complete blood counts. Both ratios were compared to the perioperative outcomes and median survival times. Association between LCR and postoperative tumour stage was studied by using multivariate analysis with other clinicopathological variables. Results A total of 123 patients were included. The mean age of the patients was 65.36 ± 10.08 …
Anahtar Kelimeler
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 18
Could lymphocyte to C‐reactive protein ratio predict the prognosis in patients with gastric cancer?

Paylaş